Hormone replacement therapy appears to be safe after prophylactic adnexectomy in premenopausal BRCA1/BRCA2 mutation carriers

Jan Lubiński*, Henry T. Lynch, Rita Schmutzler, Monique M.A. Brood-Van Zanten, Marius J. Van Der Mooren, René H.M. Verheijen, Peter Kenemans, Tracy Dudding, Judy Kirk, Shirley Hodgson, Lenka Foretova, Barbara Weber, Timothy R. Rebbeck, Jill E. Stopfer, Susan Domchek

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalHereditary Cancer in Clinical Practice
Issue number3
Publication statusPublished - 2005

Cite this